Category Archive

AUGUST 22 2021 By Dr. Jordan Messler Why the Next Wave of Insulin Innovation Needs to Focus on Inpatient Management In 1921, Sir Frederick G. Banting, Charles H. Best and JJR Macleod discovered insulin at the University of Toronto. This innovation changed the course of history for individuals with type 1 diabetes, caregivers and others who require insulin. The 100 …

JULY 14 2021 Steven Loeb John Downey, Chief Commercial Officer at Glytec, on VatorNews podcast Glytec’s electronic glycemic management system uses data to determine patient insulin levels Steven Loeb and Bambi Francisco interview John Downey, Chief Commercial Officer at Glytec, a provider of electronic glycemic management systems (eGMS), using real-time data to ensure that hospitals give patients the right level of insulin. …

JULY 13 2021 Sean Whooley Glytec appoints chief medical officer Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Additionally, Messler will be supporting the delivery, customer, quality and regulatory teams to ensure ethical …

APRIL 26 2021 Glytec Raises $21 Million Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million …

APRIL 26 2021 Glytec Lands $21M Venture & Debt Funding WALTHAM, MA, Glytec, a provider of insulin management software, announced $21 million in financing. >> Click here for more funding data on Glytec >> To export Glytec funding data to PDF and Excel, click here Glytec, a provider of insulin management software, announced $21 million in financing from Silicon Valley …

MAY 13 2021 Amanda Pedersen Most Riveting Takeaways from the Medtech Design Summit 2021 Finalists in the 2021 Medical Design Excellence Awards program shared best practices and lessons learned from the design process. These were among the most compelling takeaways from the discussions. The Medtech Design Summit is available to watch on demand here. View slideshow: https://www.mddionline.com/design-engineering/most-riveting-takeaways-medtech-design-summit-2021/gallery?slide=1 – This article originally …

MAY 13 2021 Medical Design Excellence Awards (MDEA) Unveils 2021 Winners SANTA MONICA, Calif.–(BUSINESS WIRE)–Medical Design Excellence Awards (MDEA), a prestigious award program recognizing cutting-edge achievements in medical product design, today announced the 2021 winners during the all-new Medtech Design Summit, during which Novo; Protolabs; HS Design, a SteriPack company; and Trelleborg sponsored sessions and Bressler Group, Inertia Engineering, and …

APRIL 26 2021 Fred Pennic Glytec Raises $21M to Fix Hospital Insulin Management What You Should Know: – Glytec announced $21M in funding today from Silicon Valley Bank, Savitr Capital and others to help address the challenge that 90% of hospitals in the U.S. face with insulin management. – Glytec’s insulin management solution, eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and …

APRIL 26 2021 Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. Editor’s Note: This article originally posted …

APRIL 27 2021 Mallory Hackett Insulin management company Glytec scores $21M to fuel growth The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement. Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors. …

APRIL 26 2021 Sean Whooley Glytec raises $21M for insulin dosing management tech Glytec announced today that it raised $21 million in financing to fund its glycemic management technology. Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a …

APRIL 27 2021 Glytec Raises $21M in Funding Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included:$9m debt financing from SVB, and$12m equity investment led by Savitr Capital and other private investors. Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company …

MAY 9 2021 Omar Ford Looking at the Major Trends in this Year’s MDEA Program COVID-19 and digital health are two subjects that loomed largely in this year’s Medical Design Excellence Awards (MDEA) Program.  The prestigious award program—recognizing cutting-edge achievements in medical product design since 1998— spans 11 categories and celebrates the Best in Show and MD+DI Readers’ Choice. (For …

APRIL 26 2021 Christine Hall Exclusive: Glytec Raises $21M Round For In-hospital Glycemic Management Glytec is developing software that aims to set the standard for insulin dosing and glycemic management in hospitals. On Monday, the company brought in a new round of $21 million in equity and debt financing. More than 34 million Americans today live with diabetes, while 88 million live …

APRIL 26 2021 Steven Loeb Insulin management software provider Glytec raises $21M The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don’t are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven’t invested in …

APRIL 26 2021 Steven Loeb Insulin management software provider Glytec raises $21M The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don’t are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven’t invested in …